Novartis launches new cell and gene therapy at Dubai’s 2020 Expo

UAE- Novartis, a Swiss pharmaceutical multinational that is currently involved in cell and gene therapy innovation, has been able to assist five young patients from the UAE who were facing the threat of progressive blindness. Dr Ahmed Baly, chief scientific officer at Novartis Gulf, during a presentation on cutting-edge cell and gene therapy innovations titled ‘Remaining Medicine’ at Expo 2020 Dubai said: “These five young individuals would have suffered progressive loss of sight. Our one-time treatment based on cell and gene therapy was successfully able to prevent further deterioration of…

Read More

Zimbabwe bags pharmaceutical deal with Dubai’s Intrapharm Group

ZIMBABWE – The government of Zimbabwe has signed a Memorandum of Understanding with one of Dubai’s largest pharmaceutical companies, Intrapharm Group, that could result in the United Arab Emirates (UAE) -based pharmaceutical company setting up a manufacturing facility and distribution base in Zimbabwe. Professor Mthuli Ncube, Minister of Finance and Economic Development, signed the letter of intent on behalf of the Government of Zimbabwe while the Chairman of the Intrapharm Group, engineer Ahmad Yousef Ibrahim, signed on behalf of the marketing and sales company for pharmaceutical products in Dubai. Minister…

Read More

Emirates SkyCargo clinches global milestone transporting pharma products

DUBAI – Emirates SkyCargo, the world leader in temperature-sensitive pharmaceutical air transport, has achieved a remarkable operational milestone having moved over 400 million kilos of pharmaceuticals in just five years. Emirates SkyCargo has raised the bar in the air cargo industry for the safe and efficient transport of pharmaceuticals in September 2016 by launching its dedicated GDP certified pharma handling facility at Dubai International Airport and unveiling its three-tiered specialized product – Emirates Pharma. Emirates SkyCargo launched the pharma corridors initiative across select destinations on its network in response to…

Read More

Al Jalila Foundation receives USD 59.8 million donor funding to establish Hamdan Bin Rashid Cancer Charity Hospital

DUBAI – Al Jalila Foundation, a member of the Mohammed bin Rashid Al Maktoum Global Initiatives, announced that it has already raised over 59 million USD to establish the Hamdan Bin Rashid Cancer Charity Hospital to help cancer patients in need. The UAE’s first charity hospital will accelerate the UAE’s efforts to be a leader in cancer care and a pioneer in medical innovation shaping the future of medicine. Al Jalila Foundation is investing AED750 million in the 250-bed hospital spanning 50,000 square metres, which will be built in two…

Read More